Understanding the Global In Vitro Lung Model IndustryUnderstanding the Global In Vitro Lung Model Industry

The rising prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, lung cancer, and others is one of the key factors boosting the demand for in In Vitro Lung Models globally. As per the WHO, COPD is projected to be the third leading cause of death worldwide by 2030. Similarly, lung cancer remains one of the deadliest cancers, causing over 1.8 million deaths annually. These diseases impose a huge economic burden on healthcare systems. In vitro lung models help researchers efficiently study disease pathology and screen drugs with human lung cells and tissues outside a living organism. This reduces dependence on animal testing and speeds up the drug development process.

Get More Insights On In Vitro Lung Models

Explore More Related Articles Gene Therapy Market

For Deeper Insights, Find the Report in the Language that You want.

FrenchGermanItalianRussianJapaneseChineseKoreanPortuguese

#invitrolungmodels, #lungresearch, #tissueengineering, #respiratoryhealth, #drugtesting, #coherentmarketinsights